| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 91 |
| 1 | ASPIRIN | 52 |
| 2 | ASPIRIN 325 MG | 50 |
| 3 | ASPIRIN 81 MG | 50 |
| 4 | SIMVASTATIN | 50 |
| 5 | SPIRONOLACTONE | 43 |
| 6 | WARFARIN | 35 |
| 7 | ALLOPURINOL | 32 |
| 8 | OMEPRAZOLE MAGNESIUM | 31 |
| 9 | POTASSIUM CHLORIDE | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SENNOSIDES, DOCUSATE SODIUM | 1 | 0.0250 |
| 1 | ARSENICUM ALBUM, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM, IODIUM, LYCOPODIUM, PULSATILLA | 1 | 0.0145 |
| 2 | ZONGERTINIB | 1 | 0.0060 |
| 3 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 4 | VADADUSTAT | 1 | 0.0033 |
| 5 | TEPOTINIB HYDROCHLORIDE | 2 | 0.0029 |
| 6 | BARIUM SULFATE | 1 | 0.0023 |
| 7 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 8 | CHLOROTHIAZIDE SODIUM | 2 | 0.0022 |
| 9 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 114 |
| 1 | Corticosteroid [EPC] | 87 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 80 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 65 |
| 4 | Aldosterone Antagonist [EPC] | 56 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 52 |
| 6 | Osmotic Laxative [EPC] | 48 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 44 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 41 |
| 9 | beta-Adrenergic Blocker [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 5 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 6 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 8 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |